Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -18.95% vs 2.22% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -26.27% vs 6.98% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -37.87% vs 13.42% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -4.54% vs -11.83% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Teva Pharmaceutical Industries Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -18.95% vs 2.22% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -10.79% vs -0.58% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -26.27% vs 6.98% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 44.80% vs 151.77% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -37.87% vs 13.42% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -7.06% vs -1.40% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -4.54% vs -11.83% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -35.33% vs 17.91% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






